(Date:12/4/2008)...ire-FirstCall/ -- MiddleBrook,Pharmaceuticals, In...opened its,administrative and sales office in Wes...will continue to house certain personnel and funct...pment group. The newly leased 14,971 square,foot...mployees as MiddleBrook,grows. , MiddleBrook P...
(Date:12/4/2008)...wire/ -- BAPTIST HEALTH, a six-hospital,system ba...health system, has,expanded its use of Clinical X...tion that enabled the system,s pharmacists to incr...re than $1 million. , "Data we collected fo...CareFocus prompts approximately half of the pharma...
(Date:12/4/2008)...en with standard dose of daunorubicin, study shows...- A high dose of the chemotherapy drug daunorubici...untreated acute myeloid leukemia (AML), preliminar...l Cancer Institute (NCI) show. , AML is a cance...d 633 patients, aged 16 to 60, who were randomly a...
(Date:12/4/2008)...ders of Virginia, Maryland and D.C. AIDS Offices ,...e/ -- Nationally, Washington, D.C. ranks first in ...2 percent are African American. In an effort to i...outh, today,s Living Quilt roundtable at the Geor...ders of the Virginia, Maryland and District of Col...
Breaking Medicine News(10 mins):Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 2Health News:Southern AIDS Living Quilt Raises Awareness in Washington, D.C. 3...l infections with an antibiotic gel reduced the pr...oughout the body,// pointing to further evidence o...ealth, investigators from the University at Buffal.... The investigators divided a sample of 100 adult...
...diation may cause skin cancer, but it also prevent... According to many, UV-B - the solar radiation tha..., and other skin cancers. That is generally true, ...that the reverse may also be the case - that UV-B ...
...icals Ltd today said its newly- found andti-diabet... trials by later this year. Mr Glenn Saldanha, Exe...wspersons that the company’s R&D team has establis... this molecule.// The global diabetes market is e...
...f bypass patients suffer mental decline after bypa...mbering. One leading theory is that the heart-lung...udy,// the loss of mental sharpness suffered by ma...gery may not be caused by the heart-lung machine u...
Other Medicine News:(Date:12/3/2008)... Sangamo BioSciences, Inc...ll provide an update on milestones,achieved in 20...al Investor,and Analyst Briefing to be held in Ne...ident of Sigma-Aldrich Corporation,s Research,Bio...xpected potential of the,two companies, collabora...
(Date:12/3/2008)...., Dec. 3 The Leukemia & Lymph... the beginning of a new clinical trial of ISF35, a... San Diego (UCSD). , , LLS is collaborat...the development and approval of a novel approach a...ory and/or 17p deleted chronic lymphocytic leukemi...
(Date:12/3/2008).... 3 Isogen, a contract development...ng, announced it has retained a,strategic financi...e global,biopharma demand for Isogen,s services. ...ful first round series of capital,investment and ...Q1 2009 to,deliver on the previously unmet proces...
(Date:12/3/2008)...., Dec. 3 Bionovo, Inc.,...s reviewed the company,s,manufacturing and contro...idance on how Bionovo can move forward with the de...enopausal hot flashes. , "We have concluded...g to,address the Agency,s recommendations for fur...
Breaking Medicine Technology:Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4Costs of climate change state by state 3A Billions says UMD 4171 1Costs of climate change state by state 3A Billions says UMD 4171 2Costs of climate change state by state 3A Billions says UMD 4171 3Costs of climate change state by state 3A Billions says UMD 4171 4The Risk Management and Patient Safety Institute Announces 2008 2009 Annual Risk Management Conference Dates 24286 1The Risk Management and Patient Safety Institute Announces 2008 2009 Annual Risk Management Conference Dates 24286 2GlaxoSmithKline Q2 Results and Strategy Update Interview with CEO 6685 1Autisms social struggles due to disrupted communication networks in brain 24279 1Autisms social struggles due to disrupted communication networks in brain 24279 2...ssion Reports EORTC 40983 (EPOC),Intergroup Study ...all/ -- Results of the,randomized phase III EORTC ... for the first time that peri-operative (pre and p...ection) in,combination with a standard chemotherap...rin (5-FU/LV)) given to patients with,resectable l...
...s Presented at Society of Nuclear,Medicine Annual ...irstCall/ --,Immunomedics, Inc. , a biopharmaceuti...odies to treat cancer and other serious,diseases, ...igen,(CEA) antibody, labetuzumab, labeled with the...d active when given in two doses,to patients with ...
Other Medicine Technology:The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5Large solid mallet with patented Ortho-Grip® silicone rubber handle.
Angled ring curette.
Perisoteal rasp for elevating, dissecting, and scraping.
Stainless steel bone clamp.
Medicine Products: